Korean J Gastroenterol.  2023 Dec;82(6):310-312. 10.4166/kjg.2023.137.

Immunoglobulin G4-related Disease

• Moon SH

• KMID: 2549816
• DOI: http://doi.org/10.4166/kjg.2023.137

Figure

• 

  Fig. 1 Systemic involvement of IgG4-related disease. (A) Lacrimal involvement. (B) Salivary involvement. (C) Colorectal involvement. (D) Pancreatic involvement. (E) Chest involvement.

• 

  Fig. 2 Follow-up images 4 weeks after steroid therapy.

Reference

1. Inoue D, Yoshida K, Yoneda N, et al. 2015; IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 94:e680. DOI: 10.1097/MD.0000000000000680. PMID: 25881845. PMCID: PMC4602507.

2. Shimosegawa T, Chari ST, Frulloni L, et al. 2011; International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 40:352–358. DOI: 10.1097/MPA.0b013e3182142fd2. PMID: 21412117.

3. Wallace ZS, Naden RP, Chari S, et al. 2020; The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 79:77–87. DOI: 10.1136/annrheumdis-2019-216561. PMID: 31796497.

4. Okazaki K, Chari ST, Frulloni L, et al. 2017; International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 17:1–6. DOI: 10.1016/j.pan.2016.12.003. PMID: 28027896.

5. Yoon SB, Moon SH, Kim JH, Park JW, Kim SE, Kim MH. 2021; Determination of the duration of glucocorticoid therapy in type 1 autoimmune pancreatitis: A systematic review and metaanalysis. Pancreatology. 21:1199–1207. DOI: 10.1016/j.pan.2021.05.303. PMID: 34090808.